Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Olivennes

Showing results (91-100 of 115) with videos related to

Pageof 12
Sort By:
Human Reproduction (Oxford, England)|June 1, 1996
A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3F Olivennes, C Righini, R Fanchin, et al.
Reproductive Biomedicine Online|July 2, 2003
Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility studyJ B Engel, F Olivennes, R Fanchin, et al.
Reproductive Biomedicine Online|January 19, 2015
Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfaF Olivennes, G Trew, A Borini, et al.
Contraception, Fertilite, Sexualite (1992)|December 1, 1996
[Ovarian stimulation using a protocol of low dose agonist in patients with an elevated basal FSH]F Olivennes, C Righini, R Fanchin, et al.
Human Reproduction (Oxford, England)|April 30, 1999
Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulationC Rongières-Bertrand, F Olivennes, C Righini, et al.
Human Reproduction (Oxford, England)|September 2, 1999
Pregnancies, growth and development of children conceived by subzonal injection of spermatozoaC Patrat, J P Wolf, S Epelboin, et al.
Contraception, Fertilite, Sexualite (1992)|May 1, 1997
[Follow-up of a cohort of 422 children aged from 6 to 13 and conceived by in vitro fertilization]F Olivennes, V Kerbrat, P Rufat, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 1, 1993
Per-urethral transvesical first-trimester amniocentesisR Frydman, J C Pons, E Borghi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilizationB C Fauser, D de Jong, F Olivennes, et al.
Prenatal Diagnosis|November 1, 1992
Prenatal diagnosis of second-trimester congenital varicella syndromeJ C Pons, F Rozenberg, M C Imbert, et al.
Pageof 12

Showing results (91-100 of 115) with videos related to

Sort By:
Pageof 12
Human Reproduction (Oxford, England)|June 1, 1996
A protocol using a low dose of gonadotrophin-releasing hormone agonist might be the best protocol for patients with high follicle-stimulating hormone concentrations on day 3F Olivennes, C Righini, R Fanchin, et al.
Reproductive Biomedicine Online|July 2, 2003
Single dose application of cetrorelix in combination with clomiphene for friendly IVF: results of a feasibility studyJ B Engel, F Olivennes, R Fanchin, et al.
Reproductive Biomedicine Online|January 19, 2015
Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfaF Olivennes, G Trew, A Borini, et al.
Contraception, Fertilite, Sexualite (1992)|December 1, 1996
[Ovarian stimulation using a protocol of low dose agonist in patients with an elevated basal FSH]F Olivennes, C Righini, R Fanchin, et al.
Human Reproduction (Oxford, England)|April 30, 1999
Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulationC Rongières-Bertrand, F Olivennes, C Righini, et al.
Human Reproduction (Oxford, England)|September 2, 1999
Pregnancies, growth and development of children conceived by subzonal injection of spermatozoaC Patrat, J P Wolf, S Epelboin, et al.
Contraception, Fertilite, Sexualite (1992)|May 1, 1997
[Follow-up of a cohort of 422 children aged from 6 to 13 and conceived by in vitro fertilization]F Olivennes, V Kerbrat, P Rufat, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 1, 1993
Per-urethral transvesical first-trimester amniocentesisR Frydman, J C Pons, E Borghi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilizationB C Fauser, D de Jong, F Olivennes, et al.
Prenatal Diagnosis|November 1, 1992
Prenatal diagnosis of second-trimester congenital varicella syndromeJ C Pons, F Rozenberg, M C Imbert, et al.
Pageof 12